|
COVI-VAC (U
CoviVac may refer to: Vaccine * CoviVac (Russia COVID-19 vaccine), inactivated COVID-19 vaccine developed by the Chumakov Centre in Russia (russian: КовиВак) * Covivac (Vietnam COVID-19 vaccine), viral vector COVID-19 vaccine developed by Institute of Vaccines and Medical Biologicals in Vietnam, later named NDV-HXP-S * COVI-VAC (U.S. COVID-19 vaccine), codenamed ''CDX-005''; live-attenuated COVID-19 vaccine developed by Codagenix Inc.; produced at the Serum Institute of India See also * COVID-19 vaccine A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 ( COVID19). Prior to the COVID19 pandemic, an e ... * * Covi (other) * VAC (other) {{disambiguation ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
CoviVac (Russia COVID-19 Vaccine)
CoviVac (russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the , which is an institute of the Russian Academy of Sciences. It was approved for use in Russia in February 2021, being the third COVID-19 vaccine to get approval in Russia. It obtained a permission for phase III clinical trial on 2 June 2021. Medical use The CoviVac shot is given in two doses, 14 days apart. It is transported and stored at normal refrigerated temperatures, of 2 to 8 degrees Celsius (35.6 to 46.4 Fahrenheit). Efficacy has not yet been established in a phase III clinical trial. Chemistry One dose of 0.5 ml is composed only of 3 μg or more of SARS-CoV-2 strain AYDAR-1 antigen inactivated by beta-propiolactone and the following excipients: * 0.3–0.5 mg of aluminum hydroxide (adjuvant) * 0.5 ml or less of phosphate buffer solution composed of disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate, sodium chloride, and water for injection Man ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
NDV-HXP-S
NDV-HXP-S (known as ButanVac or ADAPTCOV in Brazil, COVIVAC in Vietnam, HXP-GPOVac in Thailand, Patria in Mexico) is a COVID-19 vaccine candidate developed under the leadership of Peter Palese, Adolfo García-Sastre, and Florian Krammer at the Icahn School of Medicine at Mount Sinai. The name NDV-HXP-S comes from the terms ''Newcastle disease virus'', ''HexaPro'', and ''spike'' protein. The stabilization of the S protein of Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 (''HexaPro'') was achieved by Jason McLellan from the University of Texas at Austin. Pharmacology NDV-HXP-S uses the Virulent Newcastle disease, Newcastle disease virus as its viral vector. The platform can be live or Inactivated vaccine, inactivated. Manufacturing Unlike vaccines such as Moderna's mRNA-1273, the Janssen COVID-19 vaccine, Janssen vaccine, and Pfizer–BioNTech's Tozinameran, which all require both specialized manufacturing facilities and also rare or expensive ingredients, NDV- ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
COVI-VAC (U
CoviVac may refer to: Vaccine * CoviVac (Russia COVID-19 vaccine), inactivated COVID-19 vaccine developed by the Chumakov Centre in Russia (russian: КовиВак) * Covivac (Vietnam COVID-19 vaccine), viral vector COVID-19 vaccine developed by Institute of Vaccines and Medical Biologicals in Vietnam, later named NDV-HXP-S * COVI-VAC (U.S. COVID-19 vaccine), codenamed ''CDX-005''; live-attenuated COVID-19 vaccine developed by Codagenix Inc.; produced at the Serum Institute of India See also * COVID-19 vaccine A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 ( COVID19). Prior to the COVID19 pandemic, an e ... * * Covi (other) * VAC (other) {{disambiguation ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
COVID-19 Vaccine
A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 ( COVID19). Prior to the COVID19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This knowledge accelerated the development of various vaccine platforms during early 2020. The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe illness. In January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by March 2020, the global pharmaceutical industry announced a major commitment to address COVID19. In 2020, the first COVID19 vaccines were developed and made available to the public through emergency authorizations and conditional approvals. Initially, most COVID19 vaccines were two ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Covi
Covi is a surname of Italian origin. Notable people with this surname include: * Alessandro Covi (born 1998), Italian cyclist rider * Andrea Covi (born 1968), Italian sprint canoer * Francis Covi (1906-1966), Dahomeyan politician and educator * Carlo Covi (born 1961), Italian Venetist politician * Tizza Covi (born 1978), Italian screenwriter and director See also * Covini Engineering Covini Engineering is an Italian car manufacturer that was formed in 1978 by Ferruccio Covini. The company is generally best known for the Covini C6W, a 6-wheeled sports car that has two axles (four wheels) in the front of the car. This company Is ..., Italian car manufacturer {{surname Italian-language surnames it:Covi ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
.jpg "Click for more on -> COVID-19 Vaccine")